G01N 33/5023
On expression patterns
Official title: {on expression patterns}
G01N33/5023 (On expression patterns) appears on 891 US grants and 2,187 published applications in this corpus.
Search patents in G01N- Granted patents
- 891
- Published applications
- 2,187
- Assignees
- 1,063
- Inventors
- 4,731
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 2 | 0 |
| 1998 | 3 | 0 |
| 1999 | 13 | 0 |
| 2000 | 5 | 0 |
| 2001 | 7 | 3 |
| 2002 | 7 | 29 |
| 2003 | 9 | 74 |
| 2004 | 9 | 58 |
| 2005 | 7 | 68 |
| 2006 | 29 | 94 |
| 2007 | 20 | 91 |
| 2008 | 19 | 71 |
| 2009 | 23 | 76 |
| 2010 | 30 | 79 |
| 2011 | 40 | 79 |
| 2012 | 36 | 68 |
| 2013 | 30 | 70 |
| 2014 | 37 | 119 |
| 2015 | 45 | 126 |
| 2016 | 47 | 135 |
| 2017 | 61 | 117 |
| 2018 | 74 | 107 |
| 2019 | 57 | 101 |
| 2020 | 57 | 78 |
| 2021 | 49 | 81 |
| 2022 | 43 | 113 |
| 2023 | 26 | 70 |
| 2024 | 41 | 97 |
| 2025 | 30 | 106 |
| 2026 | 33 | 77 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Complex microfluidic models for ALS including NF biomarkers for ALS research and drug development29 Sep 2026US 12,748,102 B2Cedars-Sinai Medical Center
- Methods for selecting and treating cancer with FGFR3 inhibitors29 Sep 2026US 12,748,103 B2GeneCentric Therapeutics, Inc.
- Receptors for cyclic dinucleotides and methods for screening agonists or inhibitors thereof15 Sep 2026US 12,736,524 B2Guangzhou Winkey Technology Co., Ltd.
- Diagnostic methods for neural disorders15 Sep 2026US 12,736,528 B2Quiver Holdings Inc.
- Composition for diagnosis or treatment of anticancer drug resistance25 Aug 2026US 12,716,888 B2
- Trem2 agonists for the stimulation of microglia and methods of identification8 Oct 2026US 2026/0306439 A1The Translational Genomics Research Institute
- Composition for inducing immunotolerance8 Oct 2026US 2026/0306540 A1
- Targeting gpatch8 for treating sf3b1-mutant cancers8 Oct 2026US 2026/0306672 A1Fred Hutchinson Cancer Center
- Anti-cancer treatments and methods of use thereof8 Oct 2026US 2026/0308535 A1
- Selective glucocorticoid receptor modifiers for treating impaired skin wound healing1 Oct 2026US 2026/0294918 A1Akribes Biomedical GmbH
Most cited
By later US patents
- Patient classification703US 6,763,307 B2Bioseek, Inc. · 2004
- In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny316US 5,750,376 ANeurospheres Holdings Ltd. · 1998
- Cells for drug discovery294US 6,689,558 B2Sangamo BioSciences, Inc. · 2004
- In vitro growth and proliferation of multipotent neural stem cells and their progeny265US 5,851,832 ANeurospheres, Ltd. · 1998
- Neural transplantation using proliferated multipotent neural stem cells and their progeny176US 6,497,872 B1Neurospheres Holdings Ltd. · 2002